These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24256719)

  • 1. AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan.
    Yagi H; Nakagawa N; Saito T; Kiyonari H; Abe T; Toda T; Wu SW; Khoo KH; Oka S; Kato K
    Sci Rep; 2013 Nov; 3():3288. PubMed ID: 24256719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding.
    Patnaik SK; Stanley P
    J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
    Zhang P; Hu H
    Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
    Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
    Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent Advances in α-dystroglycanopathy].
    Kuga A; Kanagawa M; Toda T
    Brain Nerve; 2011 Nov; 63(11):1189-95. PubMed ID: 22068471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
    Manya H; Endo T
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large induces functional glycans in an O-mannosylation dependent manner and targets GlcNAc terminals on alpha-dystroglycan.
    Hu Y; Li ZF; Wu X; Lu Q
    PLoS One; 2011 Feb; 6(2):e16866. PubMed ID: 21347376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
    Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
    J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HNK-1 sulfotransferase-dependent sulfation regulating laminin-binding glycans occurs in the post-phosphoryl moiety on α-dystroglycan.
    Nakagawa N; Takematsu H; Oka S
    Glycobiology; 2013 Sep; 23(9):1066-74. PubMed ID: 23723439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.
    Hara Y; Kanagawa M; Kunz S; Yoshida-Moriguchi T; Satz JS; Kobayashi YM; Zhu Z; Burden SJ; Oldstone MB; Campbell KP
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17426-31. PubMed ID: 21987822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
    Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
    Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
    Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.
    Kuga A; Kanagawa M; Sudo A; Chan YM; Tajiri M; Manya H; Kikkawa Y; Nomizu M; Kobayashi K; Endo T; Lu QL; Wada Y; Toda T
    J Biol Chem; 2012 Mar; 287(12):9560-7. PubMed ID: 22270369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.
    Bao X; Kobayashi M; Hatakeyama S; Angata K; Gullberg D; Nakayama J; Fukuda MN; Fukuda M
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12109-14. PubMed ID: 19587235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.
    Inamori K; Yoshida-Moriguchi T; Hara Y; Anderson ME; Yu L; Campbell KP
    Science; 2012 Jan; 335(6064):93-6. PubMed ID: 22223806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycomic analyses of mouse models of congenital muscular dystrophy.
    Stalnaker SH; Aoki K; Lim JM; Porterfield M; Liu M; Satz JS; Buskirk S; Xiong Y; Zhang P; Campbell KP; Hu H; Live D; Tiemeyer M; Wells L
    J Biol Chem; 2011 Jun; 286(24):21180-90. PubMed ID: 21460210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V.
    Lee JK; Matthews RT; Lim JM; Swanier K; Wells L; Pierce JM
    J Biol Chem; 2012 Aug; 287(34):28526-36. PubMed ID: 22715095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDP-glycerol inhibits the synthesis of the functional
    Imae R; Manya H; Tsumoto H; Osumi K; Tanaka T; Mizuno M; Kanagawa M; Kobayashi K; Toda T; Endo T
    J Biol Chem; 2018 Aug; 293(31):12186-12198. PubMed ID: 29884773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesion.
    Noor SI; Hoffmann M; Rinis N; Bartels MF; Winterhalter PR; Hoelscher C; Hennig R; Himmelreich N; Thiel C; Ruppert T; Rapp E; Strahl S
    J Biol Chem; 2021; 296():100433. PubMed ID: 33610554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GTDC2 modifies O-mannosylated α-dystroglycan in the endoplasmic reticulum to generate N-acetyl glucosamine epitopes reactive with CTD110.6 antibody.
    Ogawa M; Nakamura N; Nakayama Y; Kurosaka A; Manya H; Kanagawa M; Endo T; Furukawa K; Okajima T
    Biochem Biophys Res Commun; 2013 Oct; 440(1):88-93. PubMed ID: 24041696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.